In NSCLC, single-cell RNA sequencing (scRNA-seq) of immune cells within tumors identifies a distinct subset of CD49a+ CD103+ tissue-resident memory (TRM) CD8+ T-cells that have capacity to respond to neoantigens but are functionally suppressed (Caushi et al., 2021). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.